Clinical trial
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects…
NCT00113750 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00113750 |
|---|---|
| Title | Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen |
| Official title | A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Tree MATA in Subjects Allergic to Tree Pollen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | TreeMATA MPL |
| Enrollment | 70 |
| Start date | Jul 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jun 13, 2005 |
| Last update posted | Jun 17, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: